Reaction

Product Residue Present reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 5,233 reports · 92 co-occurring drugs

As of the last recalculation, Product Residue Present appears in 5,233 FAERS reports alongside 92 co-occurring drug terms. The strongest observed disproportionality signal is LEVODOPA (PRR 207.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Levodopa	562	207.1	217.2
Upadacitinib	540	29.3	29.5
Carbidopa And Levodopa	263	23.2	23.3
Icosapent Ethyl	47	22.1	22.3
Rasagiline Mesylate	52	18.8	18.8
Amantadine	62	16.1	16.2
Cholestyramine	45	14.9	15.0
Budesonide	198	13.9	13.9
Pramipexole	51	13.4	13.4
Desvenlafaxine Succinate	81	12.1	12.1
Mesalamine	130	9.4	9.4
Rotigotine	32	8.8	8.9
Lifitegrast	31	7.6	7.6
Ropinirole	29	7.6	7.6
Metformin Hydrochloride	88	6.0	6.0
Rivastigmine	27	5.7	5.7
Metformin Hydrochloride Tablet	81	5.7	5.7
Metformin Hydrochloride Tablets	80	5.6	5.6
Metformin Hydrochloride Extended-Release Tablets	80	5.6	5.6
Estradiol	118	5.5	5.5
Sitagliptin And Metformin Hydrochloride	29	5.4	5.4
Brinzolamide	11	5.0	5.1
Prednisolone Acetate	13	5.0	5.0
Minoxidil	56	5.0	5.0
Divalproex Sodium	57	4.9	4.9
Bupropion Hydrochloride	119	4.9	4.9
Estradiol Gel 0.1%	54	4.8	4.8
Estradiol Transdermal	54	4.8	4.8
Minocycline	14	4.8	4.8
Carboxymethylcellulose Sodium	11	4.7	4.7
Testosterone	26	4.4	4.4
Dutasteride	9	4.4	4.4
Potassium Chloride Extended-Release	100	4.4	4.4
Potassium Chloride, Dextrose Monohydrate	98	4.3	4.3
Potassium Chloride Oral	98	4.3	4.3
Potassium Chloride	120	4.3	4.3
Diltiazem Hydrochloride Extended-Release Tablets	12	4.2	4.2
Guanfacine	8	4.0	4.1
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate	38	3.7	3.7
Psyllium Husk	9	3.6	3.6
Loperamide Hydrochloride Oral	9	3.5	3.5
Ketoconazole	15	3.5	3.5
Chlorthalidone	10	3.4	3.4
Ketoconazole Foam	12	3.2	3.2
Ketoconazole Cream, 2%	12	3.2	3.2
Asenapine Maleate	7	3.2	3.2
Oxybutynin	23	3.1	3.1
Tofacitinib	138	3.0	3.0
Tretinoin	6	2.9	2.9
Loperamide Hcl	9	2.8	2.8
Travoprost	6	2.8	2.8
Linaclotide	18	2.7	2.7
Mirabegron	26	2.7	2.7
Ranolazine	7	2.7	2.7
Glipizide	40	2.6	2.6
Umeclidinium Bromide And Vilanterol Trifenatate	11	2.6	2.6
Fexofenadine Hydrochloride	14	2.6	2.6
Tamsulosin Hydrochloride	13	2.5	2.5
Losartan	110	2.5	2.5
Dorzolamide Hydrochloride And Timolol Maleate	5	2.5	2.5
Bupropion	28	2.5	2.5
Metoprolol Succinate Er Tablets	39	2.5	2.5
Methylphenidate	18	2.5	2.5
Brimonidine Tartrate	10	2.2	2.2
Methylphenidate Hydrochloride	33	2.2	2.2
Umeclidinium	5	2.2	2.2
Empagliflozin	37	2.2	2.2
Sitagliptin	39	2.2	2.2
Nintedanib	17	2.2	2.2
Latanoprost	27	2.1	2.1
Treprostinil	65	2.1	2.1
Donepezil Hydrochloride	19	2.1	2.1
Levocetirizine Dihydrochloride	12	2.0	2.0
Fluticasone Furoate And Vilanterol Trifenatate	17	1.9	1.9
Vortioxetine	8	1.9	1.9
Fluticasone Propionate And Salmeterol	18	1.7	1.7
Lurasidone Hydrochloride	8	1.5	1.5
Rifaximin	8	1.5	1.5
Loratadine And Pseudoephedrine Sulfate	3	1.5	1.5
Emtricitabine And Tenofovir Alafenamide	4	1.4	1.4
Naltrexone Hydrochloride And Bupropion Hydrochloride	3	1.4	1.4
Bimatoprost	10	1.4	1.4
Paliperidone	8	1.4	1.4
Brexpiprazole	5	1.2	1.2
Glecaprevir And Pibrentasvir	3	1.1	1.1
Diroximel Fumarate	3	1.0	1.0
Olaparib	5	1.0	1.0
Pimavanserin Tartrate	13	0.9	0.9
Glycerin, Lidocaine	3	0.9	0.9
Minoxidil Foam 5% (Womens)	7	0.8	0.8
Docosanol	3	0.8	0.8
Nirmatrelvir And Ritonavir	6	0.4	0.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.